Table 1: Patient characteristics.

 

N = 33

Age (years)

64.6 ± 9.2 (38-82)

Male patients

30 (90%)

Duration of AA (years)

1.6 ± 1.3

BMI (kg/m2)

24.6 ± 3.5

CHADS2 score

1.6 ± 0.7

Echo parameters at baseline

 

LVEF (%)

30.7 ± 10.9

LAD (mm)

45.1 ± 5.5

LVDd (mm)

54.8 ± 7.3

LVDs (mm)

46.5 ± 8.0

LVEDV (ml)

118.2 ± 37.7

LVESV (ml)

80.8 ± 32.4

Enlarged LVDd > 60 mm

7 (21%)

Drugs

 

AAD

24 (73%)

Diuretic

15 (45%)

Beta blocker

31 (94%)

ACEI

20 (%)

DOAC

31 (94%)

Warfarin

2 (6%)

Continuous variables are shown as mean ± SD.
AA: Atrial Arrhythmia; BMI: Body Mass Index; LVEF: Left Ventricular Ejection Fraction; LAD: Left Atrial Dimension; Lvdd: Left Ventricular End-Diastolic Dimension; Lvds: Left Ventricular End-Systolic Dimension; LVEDV: Left Ventricular End-Diastolic Volume; LVESV: Left Ventricular End-Systolic Volume; AAD: Anti-Arrhythmic Drug; ACEI: Angiotensin-Converting Enzyme Inhibitor; DOAC: Direct Oral Anticoagulant